Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 38

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 38
---
 relevant Change of Control Conversion Date; |

| · | the number of Series B Preferred Stock to be converted; and |

| · | that the Series B Preferred Stock are to be converted pursuant to the           
 change of control conversion right held by holders of Series B Preferred Stock. |

We will not issue fractional shares of common
stock upon the conversion of the Series B Preferred Stock.

Instead, we will pay the cash value of any fractional
share otherwise due, computed on the basis of the applicable Common Stock Share Price.

The “Change of Control Conversion Date”
is the date on which the shares of Series B Preferred Stock are to be converted, which will be a business day selected by us that
is no fewer than 20 days nor more than 35 days after the date on which we provide the notice described above to the holders of Series B
Preferred Stock.

The “Common Stock Share Price” will
be (i) if the consideration to be received in the Change of Control by the holders of our common stock is solely cash, the amount
of cash consideration per share of common stock or (ii) if the consideration to be received in the Change of Control by holders of
our common stock is other than solely cash (x) the average of the closing sale prices per share of our common stock (or, if no closing
sale price is reported, the average of the closing bid and ask prices or, if more than one in either case, the average of the average
closing bid and the average closing ask prices) for the 10 consecutive trading days immediately preceding, but not including, the effective
date of the Change of Control as reported on the principal U.S. securities exchange on which our common stock is then traded, or (y) the
average of the last quoted bid prices for our common stock in the over-the-counter market as reported by OTC Markets Group, Inc.
or similar organization for the 10 consecutive trading days immediately preceding, but not including, the effective date of the Change
of Control, if our common stock is not then listed for trading on a U.S. securities exchange.

Limited Voting Rights

Holders of the Series B Preferred Stock generally
will have no voting rights. However, if we are in arrears on dividends, whether or not authorized or declared, on the Series B Preferred
Stock for six or more quarterly periods, whether or not consecutive, holders of Series B Preferred Stock (voting as a single class
together with the holders of the Series A Preferred Stock